Godavari Biorefineries has received a US patent for compounds that target cancer stem cells, showing potential for treating breast and prostate cancers. Following the announcement, the company shares jumped 17%, with heavy trading volume. The patent grants exclusive US rights, opens opportunities for global partnerships, and could lead to safer, more effective cancer therapies.